Risk of high-grade bleeding in patients with cancer treated with bevacizumab: a meta-analysis of randomized controlled trials

被引：0
|
作者：
Xiao Feng Hang
Wen Sheng Xu
Jun Xue Wang
Lei Wang
Hai Guang Xin
Rui Qi Zhang
Wu Ni
机构：
[1] Second Military Medical University,Department of Infectious diseases, Changzheng Hospital
来源：
European Journal of Clinical Pharmacology | 2011年 / 67卷
关键词：
Bevacizumab; Bleeding; Meta-analysis; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：613 / 623
页数：10
相关论文
共 50 条
  • [21] Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: a meta-analysis of randomized controlled trials
    Zhou, Jian xin
    Feng, Li jin
    Zhang, Xi
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 3009 - 3017
  • [22] Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: A meta-analysis of randomized controlled trials
    Ranpura, Vishal
    Hapani, Sanjaykumar
    Chuang, Jeff
    Wu, Shenhong
    [J]. ACTA ONCOLOGICA, 2010, 49 (03) : 287 - 297
  • [23] Incidence and risk of hypertension with bevacizumab in non-small-cell lung cancer patients: a meta-analysis of randomized controlled trials
    Chen, Jian
    Lu, Yingfeng
    Zheng, Yunliang
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 4751 - 4760
  • [24] BEVACIZUMAB-BASED CHEMOTHERAPY AND THROMBOTIC EVENTS RISK IN COLORECTAL CANCER PATIENTS: A META-ANALYSIS STUDY OF RANDOMIZED CONTROLLED TRIALS
    Alahmari, A. K.
    Guo, J. J.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A72 - A72
  • [25] Risk of Anemia Attributable to Everolimus in Patients with Cancer: A Meta-analysis of Randomized Controlled Trials
    Shameem, Raji
    Hamid, Muhammad Saad
    Wu, Shenhong
    [J]. ANTICANCER RESEARCH, 2015, 35 (04) : 2333 - 2340
  • [26] Risk of infection in patients with atopic dermatitis treated with dupilumab: A meta-analysis of randomized controlled trials
    Fleming, Patrick
    Drucker, Aaron M.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (01) : 62 - +
  • [27] Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis
    Hapani, Sanjaykumar
    Chu, David
    Wu, Shenhong
    [J]. LANCET ONCOLOGY, 2009, 10 (06): : 559 - 568
  • [28] Risk of cancer in patients treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trials
    Ilaria Dicembrini
    Besmir Nreu
    Chiara Montereggi
    Edoardo Mannucci
    Matteo Monami
    [J]. Acta Diabetologica, 2020, 57 : 689 - 696
  • [29] Risk of Venous Thromboembolic Events in Patients With Cancer Treated With Aflibercept: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Kanukula, Raju
    Ganta, Shruthi
    Sirumalla, Yashaswee
    Salam, Abdul
    Baddam, Ravali
    Pasupuleti, Bhuvana C.
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (04) : E549 - E552
  • [30] Risk of cancer in patients treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trials
    Dicembrini, Ilaria
    Nreu, Besmir
    Montereggi, Chiara
    Mannucci, Edoardo
    Monami, Matteo
    [J]. ACTA DIABETOLOGICA, 2020, 57 (06) : 689 - 696
12345